Form 8-K - Current report:
SEC Accession No. 0001837607-26-000005
Filing Date
2026-01-21
Accepted
2026-01-21 16:06:10
Documents
17
Period of Report
2026-01-21
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aeon-20260121x8k.htm   iXBRL 8-K 88112
2 EX-10.1 aeon-20260121xex10d1.htm EX-10.1 146536
3 EX-10.2 aeon-20260121xex10d2.htm EX-10.2 20845
4 EX-99.1 aeon-20260121xex99d1.htm EX-99.1 15802
5 GRAPHIC aeon-20260121xex99d1001.jpg GRAPHIC 3801
  Complete submission text file 0001837607-26-000005.txt   447434

Data Files

Seq Description Document Type Size
6 EX-101.SCH aeon-20260121.xsd EX-101.SCH 3542
7 EX-101.DEF aeon-20260121_def.xml EX-101.DEF 2868
8 EX-101.LAB aeon-20260121_lab.xml EX-101.LAB 17852
9 EX-101.PRE aeon-20260121_pre.xml EX-101.PRE 10674
19 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20260121x8k_htm.xml XML 5053
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 26547846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)